Article Details

Omicron-specific Sinopharm, Sinovac COVID vaccine candidates cleared for clinical trial | Reuters

Retrieved on: 2022-04-16 19:16:45

Tags for this article:

Click the tags to see associated articles and topics

Omicron-specific Sinopharm, Sinovac COVID vaccine candidates cleared for clinical trial | Reuters. View article details on HISWAI: https://www.reuters.com/business/healthcare-pharmaceuticals/omicron-specific-sinopharm-covid-vaccine-candidates-cleared-clinical-trial-2022-04-16/

Excerpt

COVID-19 vaccine candidates developed by a Sinopharm subsidiary and Sinovac Biotech to target the Omicron variant were approved for clinical ...

Article found on: www.reuters.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up